Early Outcomes With Direct Flow Medical Versus First-Generation Transcatheter Aortic Valve Devices: A Single-Center Propensity-Matched Analysis.

@article{Giustino2015EarlyOW,
  title={Early Outcomes With Direct Flow Medical Versus First-Generation Transcatheter Aortic Valve Devices: A Single-Center Propensity-Matched Analysis.},
  author={Gennaro Giustino and Azeem Latib and Vasileios F. Panoulas and Matteo Montorfano and Alaide Chieffo and Maurizio Taramasso and Katsumasa Sato and Eustachio Agricola and Ottavio R. Alfieri and Antonio Colombo},
  journal={Journal of interventional cardiology},
  year={2015},
  volume={28 6},
  pages={
          583-93
        }
}
OBJECTIVES To compare early outcomes between Direct Flow Medical (DFM) and 1(st) -generation transcatheter aortic valve replacement (TAVR) devices. BACKGROUND The effectiveness of new-generation TAVR devices compared with earlier generations is unclear. METHODS AND RESULTS Overall, 496 patients treated between November 2007 and March 2014 were included: 44 (8.7%) treated with DFM, 179 (36.9%) with Medtronic CoreValve (MCV) and 273 (54.4%) with Edwards Sapien / Sapien XT (SXT) valve. Because… CONTINUE READING
BETA

References

Publications referenced by this paper.
SHOWING 1-10 OF 22 REFERENCES

Similar Papers

Loading similar papers…